Dacquin Annie

Title: Dacquin Annie: Innovator in Uterine Fibroid Therapy

Introduction

Dacquin Annie is a notable inventor based in Cranves Sales, France. He has made significant contributions to the field of medical therapy, particularly in the treatment of uterine fibroids. His innovative approach has led to the development of a unique patent that addresses a common health issue faced by many women.

Latest Patents

Dacquin Annie holds a patent for "Progesterone receptor modulators for use in the therapy of uterine fibroids." This invention relates to a long-term therapy that includes repeated treatment courses of ulipristal acetate or any metabolite thereof for treating uterine fibroids. Additionally, the patent encompasses a combined therapy that applies ulipristal acetate with a progestin to enhance the effectiveness of current treatments for uterine fibroids.

Career Highlights

Annie's career is marked by his dedication to advancing medical therapies. He works at Preglem SA, a company focused on developing innovative solutions for women's health. His work has not only contributed to the scientific community but has also provided new hope for patients suffering from uterine fibroids.

Collaborations

Dacquin Annie collaborates with talented professionals in his field, including Bestel Elke and Osterloh Ian. These partnerships enhance the research and development process, leading to more effective therapeutic options.

Conclusion

Dacquin Annie's contributions to the field of uterine fibroid therapy exemplify the impact of innovation in medicine. His patent and work at Preglem SA highlight the importance of continued research and collaboration in developing effective treatments for women's health issues.